RecruitingNCT07171853

The Carbon Footprint Study of Colonoscopy

The Carbon Footprint Study of Colonoscopy for Colorectal Cancer Screening and Various Techniques of Colonic Polypectomy


Sponsor

King Chulalongkorn Memorial Hospital

Enrollment

150 participants

Start Date

Jun 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

With global warming intensifying, GI endoscopy is among the top three greenhouse gas-emitting medical procedures. Colonoscopy, a cornerstone for colorectal cancer (CRC) screening, significantly contributes to the carbon footprint (CF). This study quantifies CO₂ emissions in different steps of colonoscopy and evaluates the environmental impact of common polypectomy techniques to establish baseline CF data and identify opportunities for mitigation. This study included patients undergoing colonoscopy for CRC screening. CO₂ emissions were comprehensively measured at each step of the procedure (pre-, during, and post-colonoscopy), including energy consumption, all equipment and medications, waste management, and endoscopy reprocessing. Emission data were also collected for common polypectomy techniques, including cold forceps biopsy (CFB), cold snare polypectomy (CSP), hot snare polypectomy (HSP), and hot snare endoscopic mucosal resection (EMR), all performed according to standard polypectomy protocols.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria1

  • Patients aged 18-80 years

Exclusion Criteria12

  • Patient status grade III-V according to the American Society of Anesthesiologists (ASA)
  • Poor bowel preparation (grade \<6 in the Boston Bowel Preparation Scale \[BBPS\])
  • Endoscopic JNET type III or suspicion of malignancy
  • Hematologic or coagulation disorders, Plt\<140,000/mcL, INR\>1.5
  • anti-platelet/anticoagulant medication that could not be paused as recommended in the current guideline
  • Emergency colonoscopy, GI bleeding, unstable vital sign, critical ill patient
  • Inflammatory bowel disease
  • Pregnancy
  • Severe cardiopulmonary disease
  • Severe infection
  • Malignancy
  • History of allergy to IV sedative medication

Locations(1)

King Chulalongkorn Memorial Hospital

Bangkok, Bangkok, Thailand

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07171853


Related Trials